81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Vertex Pharmaceuticals's debt to equity ratio is 0.31: total debt of 6.48B USD against shareholders' equity of 20.91B USD.
- Today
- 0.31
- Average, 5 years
- 0.10
- Low, 5 years
- 0.04
- High, 5 years
- 0.31
Debt to equity = total debt ÷ shareholders' equity = 6.48B ÷ 20.91B = 0.31
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.31 | 6.48B | 20.91B | |
| FY2025 | 31 Dec 2025 | 0.21 | 3.88B | 18.67B |
| FY2024 | 31 Dec 2024 | 0.11 | 1.75B | 16.41B |
| FY2023 | 31 Dec 2023 | 0.05 | 808.40M | 17.58B |
| FY2022 | 31 Dec 2022 | 0.06 | 899.70M | 13.91B |
| FY2021 | 31 Dec 2021 | 0.10 | 967.40M | 10.10B |
| FY2020 | 31 Dec 2020 | 0.11 | 931.90M | 8.69B |
| FY2019 | 31 Dec 2019 | 0.11 | 661.66M | 6.09B |
| FY2018 | 31 Dec 2018 | 0.13 | 586.82M | 4.44B |
| FY2017 | 31 Dec 2017 | 0.30 | 606.43M | 2.03B |
| FY2016 | 31 Dec 2016 | 0.73 | 840.76M | 1.16B |
| FY2015 | 31 Dec 2015 | 0.88 | 826.24M | 939.97M |
| FY2014 | 31 Dec 2014 | 0.77 | 824.95M | 1.08B |
| FY2013 | 31 Dec 2013 | 0.37 | 506.58M | 1.36B |
| FY2012 | 31 Dec 2012 | 0.70 | 696.91M | 999.18M |
| FY2011 | 31 Dec 2011 | 0.58 | 455.95M | 786.84M |
| FY2010 | 31 Dec 2010 | 1.07 | 536.99M | 503.97M |
| FY2009 | 31 Dec 2009 | 0.17 | 185.91M | 1.10B |
| FY2008 | 31 Dec 2008 | 1.20 | 287.50M | 238.87M |
| FY2007 | 31 Dec 2007 | 0.07 | 20.00M | 271.30M |
| FY2006 | 31 Dec 2006 | 0.24 | 123.76M | 505.94M |
| FY2005 | 31 Dec 2005 | 0.75 | 180.10M | 239.18M |
| FY2004 | 31 Dec 2004 | 9.45 | 335.00M | 35.44M |
| FY2003 | 31 Dec 2003 | 1.89 | 363.85M | 192.85M |
| FY2002 | 31 Dec 2002 | 0.87 | 328.14M | 378.58M |
| FY2001 | 31 Dec 2001 | 0.69 | 327.61M | 475.35M |
| FY2000 | 31 Dec 2000 | 0.70 | 362.34M | 514.01M |
| FY1999 | 31 Dec 1999 | 0.03 | 7.06M | 209.23M |
| FY1998 | 31 Dec 1998 | 0.04 | 9.80M | 246.20M |
| FY1997 | 31 Dec 1997 | 0.03 | 8.40M | 276.00M |
| FY1996 | 31 Dec 1996 | 0.06 | 8.50M | 130.80M |
| FY1995 | 31 Dec 1995 | 0.08 | 7.00M | 85.30M |
| FY1994 | 31 Dec 1994 | 0.06 | 6.40M | 105.50M |
| FY1993 | 31 Dec 1993 | 0.12 | 6.00M | 49.50M |
| FY1992 | 31 Dec 1992 | 0.12 | 5.10M | 43.90M |
| FY1991 | 31 Dec 1991 | 0.06 | 3.30M | 52.20M |
| FY1990 | 31 Dec 1990 | 0.62 | 3.20M | 5.20M |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.31 | 6.48B | 20.91B |
| Q2 FY2026 | 30 Jun 2026 | 0.10 | 1.98B | 20.25B |
| Q1 FY2026 | 31 Mar 2026 | 0.10 | 1.99B | 19.36B |
| Q4 FY2025 | 31 Dec 2025 | 0.21 | 3.88B | 18.67B |
| Q3 FY2025 | 30 Sept 2025 | 0.11 | 1.83B | 17.32B |
| Q2 FY2025 | 30 Jun 2025 | 0.09 | 1.53B | 17.18B |
| Q1 FY2025 | 31 Mar 2025 | 0.10 | 1.65B | 16.50B |
| Q4 FY2024 | 31 Dec 2024 | 0.11 | 1.75B | 16.41B |
| Q3 FY2024 | 30 Sept 2024 | 0.11 | 1.70B | 15.63B |
| Q2 FY2024 | 30 Jun 2024 | 0.06 | 933.40M | 14.77B |
| Q1 FY2024 | 31 Mar 2024 | 0.04 | 721.30M | 18.55B |
| Q4 FY2023 | 31 Dec 2023 | 0.05 | 808.40M | 17.58B |
| Q3 FY2023 | 30 Sept 2023 | 0.05 | 744.70M | 16.51B |
| Q2 FY2023 | 30 Jun 2023 | 0.05 | 767.60M | 15.47B |
| Q1 FY2023 | 31 Mar 2023 | 0.05 | 789.20M | 14.43B |
| Q4 FY2022 | 31 Dec 2022 | 0.06 | 899.70M | 13.91B |
| Q3 FY2022 | 30 Sept 2022 | 0.06 | 824.60M | 13.03B |
| Q2 FY2022 | 30 Jun 2022 | 0.07 | 847.30M | 11.93B |
| Q1 FY2022 | 31 Mar 2022 | 0.08 | 872.50M | 10.91B |
| Q4 FY2021 | 31 Dec 2021 | 0.10 | 967.40M | 10.10B |
| Q3 FY2021 | 30 Sept 2021 | 0.09 | 876.80M | 9.53B |
| Q2 FY2021 | 30 Jun 2021 | 0.10 | 893.85M | 9.20B |
| Q1 FY2021 | 31 Mar 2021 | 0.10 | 898.80M | 8.98B |
| Q4 FY2020 | 31 Dec 2020 | 0.11 | 931.90M | 8.69B |
| Q3 FY2020 | 30 Sept 2020 | 0.07 | 546.51M | 8.13B |
| Q2 FY2020 | 30 Jun 2020 | 0.07 | 522.07M | 7.52B |
| Q1 FY2020 | 31 Mar 2020 | 0.08 | 532.95M | 6.46B |
| Q4 FY2019 | 31 Dec 2019 | 0.11 | 661.66M | 6.09B |
| Q3 FY2019 | 30 Sept 2019 | 0.12 | 604.54M | 5.25B |
| Q2 FY2019 | 30 Jun 2019 | 0.12 | 611.96M | 5.07B |
| Q1 FY2019 | 31 Mar 2019 | 0.13 | 623.87M | 4.72B |
| Q4 FY2018 | 31 Dec 2018 | 0.13 | 586.82M | 4.44B |
| Q3 FY2018 | 30 Sept 2018 | 0.20 | 588.04M | 2.91B |
| Q2 FY2018 | 30 Jun 2018 | 0.22 | 592.74M | 2.69B |
| Q1 FY2018 | 31 Mar 2018 | 0.25 | 595.13M | 2.40B |
| Q4 FY2017 | 31 Dec 2017 | 0.30 | 606.43M | 2.03B |
| Q3 FY2017 | 30 Sept 2017 | 0.33 | 587.19M | 1.79B |
| Q2 FY2017 | 30 Jun 2017 | 0.34 | 568.54M | 1.67B |
| Q1 FY2017 | 31 Mar 2017 | 0.37 | 548.40M | 1.50B |
| Q4 FY2016 | 31 Dec 2016 | 0.73 | 840.76M | 1.16B |
| Q3 FY2016 | 30 Sept 2016 | 0.80 | 820.32M | 1.02B |
| Q2 FY2016 | 30 Jun 2016 | 0.84 | 820.63M | 981.35M |
| Q1 FY2016 | 31 Mar 2016 | 0.86 | 824.49M | 957.08M |
| Q4 FY2015 | 31 Dec 2015 | 0.88 | 826.24M | 939.97M |
| Q3 FY2015 | 30 Sept 2015 | 0.89 | 820.98M | 922.15M |
| Q2 FY2015 | 30 Jun 2015 | 0.92 | 824.47M | 894.96M |
| Q1 FY2015 | 31 Mar 2015 | 0.85 | 833.91M | 976.46M |
| Q4 FY2014 | 31 Dec 2014 | 0.77 | 824.95M | 1.08B |
| Q3 FY2014 | 30 Sept 2014 | 0.72 | 828.24M | 1.16B |
| Q2 FY2014 | 30 Jun 2014 | 0.46 | 538.03M | 1.17B |
| Q1 FY2014 | 31 Mar 2014 | 0.44 | 541.18M | 1.23B |
| Q4 FY2013 | 31 Dec 2013 | 0.37 | 506.58M | 1.36B |
| Q3 FY2013 | 30 Sept 2013 | 0.35 | 446.38M | 1.26B |
| Q2 FY2013 | 30 Jun 2013 | 0.30 | 397.85M | 1.32B |
| Q1 FY2013 | 31 Mar 2013 | 0.99 | 739.88M | 746.12M |
| Q4 FY2012 | 31 Dec 2012 | 0.70 | 696.91M | 999.18M |
| Q3 FY2012 | 30 Sept 2012 | 0.39 | 400.00M | 1.03B |
| Q2 FY2012 | 30 Jun 2012 | 0.39 | 400.00M | 1.04B |
| Q1 FY2012 | 31 Mar 2012 | 0.43 | 400.00M | 930.50M |
| Q4 FY2011 | 31 Dec 2011 | 0.58 | 455.95M | 786.84M |
| Q3 FY2011 | 30 Sept 2011 | 0.86 | 498.42M | 579.76M |
| Q2 FY2011 | 30 Jun 2011 | 1.61 | 494.66M | 307.55M |
| Q1 FY2011 | 31 Mar 2011 | 1.26 | 492.10M | 391.67M |
| Q4 FY2010 | 31 Dec 2010 | 1.07 | 536.99M | 503.97M |
| Q3 FY2010 | 30 Sept 2010 | 0.75 | 487.23M | 650.10M |
| Q2 FY2010 | 30 Jun 2010 | 0.10 | 86.41M | 827.14M |
| Q1 FY2010 | 31 Mar 2010 | 0.13 | 125.32M | 990.61M |
| Q4 FY2009 | 31 Dec 2009 | 0.17 | 185.91M | 1.10B |
| Q3 FY2009 | 30 Sept 2009 | 0.43 | 262.84M | 608.74M |
| Q2 FY2009 | 30 Jun 2009 | 0.20 | 144.00M | 729.06M |
| Q1 FY2009 | 31 Mar 2009 | 0.41 | 287.50M | 706.85M |
| Q4 FY2008 | 31 Dec 2008 | 1.20 | 287.50M | 238.87M |
| Q3 FY2008 | 30 Sept 2008 | 0.82 | 287.50M | 349.89M |
| Q2 FY2008 | 30 Jun 2008 | 1.20 | 287.50M | 239.93M |
| Q1 FY2008 | 31 Mar 2008 | 0.94 | 287.50M | 304.26M |
| Q4 FY2007 | 31 Dec 2007 | 0.07 | 20.00M | 271.30M |
| Q3 FY2007 | 30 Sept 2007 | 0.06 | 20.00M | 332.04M |
| Q2 FY2007 | 30 Jun 2007 | 0.15 | 62.10M | 414.59M |
| Q1 FY2007 | 31 Mar 2007 | 0.13 | 65.23M | 501.30M |
| Q4 FY2006 | 31 Dec 2006 | 0.24 | 123.76M | 505.94M |
| Q3 FY2006 | 30 Sept 2006 | 0.20 | 101.75M | 507.77M |
| Q2 FY2006 | 30 Jun 2006 | 1.03 | 180.09M | 175.00M |
| Q1 FY2006 | 31 Mar 2006 | 0.77 | 180.10M | 232.91M |
| Q4 FY2005 | 31 Dec 2005 | 0.75 | 180.10M | 239.18M |
| Q3 FY2005 | 30 Sept 2005 | 2.21 | 294.55M | 133.31M |
| Q2 FY2005 | 30 Jun 2005 | 2.72 | 335.00M | 122.96M |
| Q1 FY2005 | 31 Mar 2005 | — | 335.00M | -8.49M |
| Q4 FY2004 | 31 Dec 2004 | 9.45 | 335.00M | 35.44M |
| Q3 FY2004 | 30 Sept 2004 | 4.30 | 319.69M | 74.32M |
| Q2 FY2004 | 30 Jun 2004 | 2.93 | 322.61M | 110.29M |
| Q1 FY2004 | 31 Mar 2004 | 2.01 | 315.04M | 157.10M |
| Q4 FY2003 | 31 Dec 2003 | 1.89 | 363.85M | 192.85M |
| Q3 FY2003 | 30 Sept 2003 | 1.49 | 345.33M | 231.28M |
| Q2 FY2003 | 30 Jun 2003 | 1.09 | 340.78M | 313.52M |
| Q1 FY2003 | 31 Mar 2003 | 0.82 | 329.90M | 400.27M |
| Q4 FY2002 | 31 Dec 2002 | 0.87 | 328.14M | 378.58M |
| Q3 FY2002 | 30 Sept 2002 | 0.79 | 324.28M | 408.21M |
| Q2 FY2002 | 30 Jun 2002 | 0.74 | 325.25M | 436.68M |
| Q1 FY2002 | 31 Mar 2002 | 0.72 | 326.26M | 450.11M |
| Q4 FY2001 | 31 Dec 2001 | 0.69 | 327.61M | 475.35M |
| Q3 FY2001 | 30 Sept 2001 | 0.75 | 358.75M | 476.29M |
| Q2 FY2001 | 30 Jun 2001 | 0.91 | 348.65M | 381.35M |
| Q1 FY2001 | 31 Mar 2001 | 0.89 | 349.15M | 390.71M |
| Q4 FY2000 | 31 Dec 2000 | 0.70 | 362.34M | 514.01M |
| Q3 FY2000 | 30 Sept 2000 | 2.26 | 511.92M | 226.61M |
| Q2 FY2000 | 30 Jun 2000 | 0.80 | 180.82M | 225.11M |
| Q1 FY2000 | 31 Mar 2000 | 0.90 | 181.43M | 201.74M |
| Q4 FY1999 | 31 Dec 1999 | 0.03 | 7.06M | 209.23M |
| Q3 FY1999 | 30 Sept 1999 | 0.04 | 7.80M | 206.50M |
| Q2 FY1999 | 30 Jun 1999 | 0.04 | 8.40M | 218.60M |
| Q1 FY1999 | 31 Mar 1999 | 0.04 | 9.10M | 229.50M |
| Q4 FY1998 | 31 Dec 1998 | 0.04 | 9.80M | 246.20M |
| Q3 FY1998 | 30 Sept 1998 | 0.04 | 10.40M | 259.10M |
| Q2 FY1998 | 30 Jun 1998 | 0.04 | 9.60M | 259.30M |
| Q1 FY1998 | 31 Mar 1998 | 0.03 | 8.70M | 268.40M |
| Q4 FY1997 | 31 Dec 1997 | 0.03 | 8.40M | 276.00M |
| Q3 FY1997 | 30 Sept 1997 | 0.03 | 8.20M | 281.50M |
| Q2 FY1997 | 30 Jun 1997 | 0.03 | 8.20M | 286.00M |
| Q1 FY1997 | 31 Mar 1997 | 0.03 | 8.10M | 275.20M |
| Q4 FY1996 | 31 Dec 1996 | 0.06 | 8.50M | 130.80M |
| Q3 FY1996 | 30 Sept 1996 | 0.05 | 6.90M | 133.70M |
| Q2 FY1996 | 30 Jun 1996 | 0.11 | 6.90M | 61.70M |
| Q1 FY1996 | 31 Mar 1996 | 0.08 | 6.50M | 78.40M |
| Q4 FY1995 | 31 Dec 1995 | 0.08 | 7.00M | 85.30M |
| Q3 FY1995 | 30 Sept 1995 | 0.08 | 6.80M | 85.60M |
| Q2 FY1995 | 30 Jun 1995 | 0.07 | 6.90M | 92.40M |
| Q1 FY1995 | 31 Mar 1995 | 0.07 | 6.60M | 100.90M |
| Q4 FY1994 | 31 Dec 1994 | 0.06 | 6.40M | 105.50M |
| Q3 FY1994 | 30 Sept 1994 | 0.07 | 6.30M | 94.70M |
| Q2 FY1994 | 30 Jun 1994 | 0.06 | 6.00M | 99.10M |
| Q1 FY1994 | 31 Mar 1994 | 0.05 | 5.50M | 104.50M |
| Q4 FY1993 | 31 Dec 1993 | 0.12 | 6.00M | 49.50M |
| Q3 FY1993 | 30 Sept 1993 | 0.15 | 5.90M | 40.60M |
| Q2 FY1993 | 30 Jun 1993 | 0.14 | 5.90M | 43.20M |
| Q1 FY1993 | 31 Mar 1993 | 0.13 | 5.30M | 40.60M |
| Q4 FY1992 | 31 Dec 1992 | 0.12 | 5.10M | 43.90M |
| Q3 FY1992 | 30 Sept 1992 | 0.11 | 5.00M | 46.50M |
| Q2 FY1992 | 30 Jun 1992 | 0.09 | 4.40M | 48.60M |
| Q1 FY1992 | 31 Mar 1992 | 0.07 | 3.60M | 50.60M |
| Q4 FY1991 | 31 Dec 1991 | 0.06 | 3.30M | 52.20M |
| Q3 FY1991 | 30 Sept 1991 | 0.13 | 3.50M | 27.80M |
| Q2 FY1991 | 30 Jun 1991 | 1.35 | 3.50M | 2.60M |
| Q1 FY1991 | 31 Mar 1991 | — | — | — |
| Q4 FY1990 | 31 Dec 1990 | 0.62 | 3.20M | 5.20M |
| Q3 FY1990 | 30 Sept 1990 | — | — | — |
| Q2 FY1990 | 30 Jun 1990 | — | — | — |
| Q1 FY1990 | 31 Mar 1990 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about Vertex Pharmaceuticals's debt to equity
Source: Financial Modeling Prep